ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

3,131
Mkt Cap
$531.53M
Volume
843,799.00
52W High
$6.71
52W Low
$2.61
PE Ratio
-35.81
ORGO Fundamentals
Price
$4.19
Prev Close
$4.28
Open
$4.27
50D MA
$4.50
Beta
1.73
Avg. Volume
967,401.67
EPS (Annual)
$0.0065
P/B
2.28
Rev/Employee
$554,710.01
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·16h ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·11d ago
News Placeholder
Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights ORGO
The DJS Law Group announces that it is investigating claims on behalf of investors of Organogenesis Holdings Inc. (Organogenesis or the Company) (NASDAQ: ORGO) for violations of the securities laws...
Business Wire·11d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·20d ago
News Placeholder
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.
investing.com·4mo ago
News Placeholder
Organogenesis (ORGO) Reports Q1 Loss, Lags Revenue Estimates
chainwire·6mo ago
News Placeholder
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Globe Newswire·2y ago
News Placeholder
Palumbo Wealth Management LLC Buys New Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Palumbo Wealth Management LLC bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and...
Ticker Report·2y ago
News Placeholder
Organogenesis Holdings Inc. (NASDAQ:ORGO) to Post FY2024 Earnings of $0.00 Per Share, Cantor Fitzgerald Forecasts
Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) Investment analysts at Cantor Fitzgerald reduced their FY2024 earnings estimates for Organogenesis in a research report issued...
Zolmax·2y ago
News Placeholder
Swiss National Bank Invests $505,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Swiss National Bank bought a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) during the 3rd quarter, according to its most recent 13F filing with the...
Zolmax·2y ago

Latest ORGO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.